TAKEDA PHARMACEUTICAL CO LTD (TAK)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch TAK
See up to 3 months of TAK. The 7-day demo opens the 1M and 3M ranges and puts TAK on your watchlist.
Start 7-day demoLatest TAK insider trades
Lauren Rusckowski Duprey - OfficerOpen-market sale$640K
About TAKEDA PHARMACEUTICAL CO LTD (TAK)
TAKEDA PHARMACEUTICAL CO LTD files with the SEC under CIK 0001395064 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TAK Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 20 | 749,336 | $13.09M |
TAK insider transactions (Form 4)
5252 Form 4 filings on record, the earliest from Apr 28, 2026, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lauren Rusckowski Duprey - Officer | Open-market sale | American Depositary Shares | 34,535 | $18.54 | $640K | |
| Andrew Stewart Plump - Officer | Open-market sale | American Depositary Shares | 116,191 | $18.49 | $2.15M | |
| Andrew Stewart Plump - Officer | Open-market sale | American Depositary Shares | 19,651 | $18.49 | $363K | |
| Nicola Deidre Petal Greenway - Officer | Open-market sale | American Depositary Shares | 12,980 | $18.11 | $235K | |
| Awny Samaan Botros Farajallah - Officer | Open-market sale | American Depositary Shares | 14,006 | $17.10 footnote F2 | $240K | |
| ||||||
| Ramy Riad Ahmed Ibrahim - Officer | Open-market sale | American Depositary Shares | 7,277 | $17.10 footnote F2 | $124K | |
| ||||||
| Rhonda Janice Pacheco - Officer | Open-market sale | American Depositary Shares | 16,901 | $17.10 footnote F2 | $289K | |
| ||||||
| Lauren Rusckowski Duprey - Officer | Open-market sale | American Depositary Shares | 47,586 | $17.10 footnote F2 | $814K | |
| ||||||
| Andrew Stewart Plump - Officer | Open-market sale | American Depositary Shares | 165,393 | $17.10 footnote F2 | $2.83M | |
| ||||||
 Agosti Marcello Pignagnoli - Officer | Open-market sale | American Depositary Shares | 22,957 | $17.10 footnote F2 | $393K | |
| ||||||
 Teresa Marie Bitetti - Officer | Open-market sale | American Depositary Shares | 50,012 | $17.10 footnote F2 | $855K | |
| ||||||
| Elaine Mary Shannon - Officer | Open-market sale | American Depositary Shares | 3,978 | $17.10 footnote F2 | $68K | |
| ||||||
| Gabriele Ricci - Officer | Open-market sale | American Depositary Shares | 25,088 | $17.10 footnote F2 | $429K | |
| ||||||
| Nicola Deidre Petal Greenway - Officer | Open-market sale | American Depositary Shares | 6,774 | $17.10 footnote F2 | $116K | |
| ||||||
 Julie So-Young Kim - Officer | Open-market sale | American Depositary Shares | 89,090 | $17.10 footnote F2 | $1.52M | |
| ||||||
 Giles Richard Platford - Officer | Open-market sale | American Depositary Shares | 31,083 | $17.10 footnote F2 | $532K | |
| ||||||
| Natalie Anne Marie Furney - Officer | Open-market sale | American Depositary Shares | 30,868 | $17.10 footnote F2 | $528K | |
| ||||||
| Elaine Mary Shannon - Officer | Open-market sale | American Depositary Shares | 20,363 | $17.55 | $357K | |
| Nicola Deidre Petal Greenway - Officer | Open-market sale | American Depositary Shares | 975 | $17.50 | $17K | |
| Nicola Deidre Petal Greenway - Officer | Open-market sale | American Depositary Shares | 33,628 | $17.51 | $589K | |
 Steven Gillis - Director | Grant or award | Ordinary Shares | 3,800 | $0.00 | - | |
| Steven Gillis - Director | Derivative | Tax Obligation Award | 1,152 | $4,931.20 footnote F4 | $5.68M | |
| Steven Gillis - Director | Grant or award | Tax Obligation Award | 1,319 | $0.00 | - | |
| ||||||
| John Maraganore - Director | Grant or award | Ordinary Shares | 3,800 | $0.00 | - | |
| John Maraganore - Director | Derivative | Tax Obligation Award | 1,152 | $4,931.20 footnote F4 | $5.68M | |
| John Maraganore - Director | Grant or award | Tax Obligation Award | 1,319 | $0.00 | - | |
| ||||||
| Kimberly A. Reed - Director | Grant or award | Ordinary Shares | 3,800 | $0.00 | - | |
| Kimberly A. Reed - Director | Derivative | Tax Obligation Award | 1,152 | $4,931.20 footnote F4 | $5.68M | |
| Kimberly A. Reed - Director | Grant or award | Tax Obligation Award | 1,319 | $0.00 | - | |
| ||||||
 Masami Iijima - Director | Grant or award | Ordinary Shares | 1,800 | $0.00 | - | |
| Masami Iijima - Director | Derivative | Tax Obligation Award | 2,152 | $4,931.20 footnote F3 | $10.61M | |
| Masami Iijima - Director | Grant or award | Tax Obligation Award | 1,937 | $0.00 | - | |
| ||||||
| Bruce D. Broussard - Director | Grant or award | American Depositary Shares | 3,800 | $0.00 | - | |
| Bruce D. Broussard - Director | Grant or award | Tax Obligation Award | 1,319 | $0.00 | - | |
| Paulus Stoffels - Director | Grant or award | Ordinary Shares | 3,800 | $0.00 | - | |
| Paulus Stoffels - Director | Grant or award | Tax Obligation Award | 1,307 | $0.00 | - | |
| Koichiro Kimura - Director | Grant or award | Ordinary Shares | 1,800 | $0.00 | - | |
| Koichiro Kimura - Director | Grant or award | Tax Obligation Award | 1,937 | $0.00 | - | |
 Miki Tsusaka - Director | Grant or award | Ordinary Shares | 1,800 | $0.00 | - | |
| Miki Tsusaka - Director | Derivative | Tax Obligation Award | 2,152 | $4,931.20 footnote F3 | $10.61M | |
| Miki Tsusaka - Director | Grant or award | Tax Obligation Award | 1,937 | $0.00 | - | |
| ||||||
 Asuka Miyabashira - Officer | Grant or award | Ordinary Shares | 1,500 | $0.00 | - | |
| Asuka Miyabashira - Officer | Derivative | Tax Obligation Award | 1,022 | $4,931.40 footnote F3 | $5.04M | |
| Asuka Miyabashira - Officer | Grant or award | Tax Obligation Award | 664 | $0.00 | - | |
| Asuka Miyabashira - Officer | Grant or award | Tax Obligation Award | 664 | $0.00 | - | |
| Asuka Miyabashira - Officer | Grant or award | Tax Obligation Award | 666 | $0.00 | - | |
| ||||||
 Milano Furuta - Officer | Grant or award | Ordinary Shares | 12,300 | $0.00 | - | |
| Milano Furuta - Officer | Derivative | Tax Obligation Award | 16,619 | $4,931.50 footnote F3 | $81.96M | |
| Milano Furuta - Officer | Grant or award | Tax Obligation Award | 4,288 | $0.00 | - | |
| Milano Furuta - Officer | Grant or award | Tax Obligation Award | 4,288 | $0.00 | - | |
| Milano Furuta - Officer | Grant or award | Tax Obligation Award | 4,288 | $0.00 | - | |
| ||||||
| Giles Richard Platford - Officer | Grant or award | American Depositary Shares | 49,558 | $0.00 | - | |
Recent TAK Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lauren Rusckowski Duprey | Chief Transformation Officer | 34,535 | $634K | View on EDGAR | |
| Plump Andrew Stewart | Officer | 116,191 |
TAK insider trading FAQ
What is the latest insider trade for TAK?
TAKEDA PHARMACEUTICAL CO LTD (TAK) had 19 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for TAK runs to 52 Form 4 filings, the earliest from 2026-04-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TAK stock?
No insider purchases of TAK were filed in the last 90 days.
How many insiders are selling TAK stock?
20 insider sales of TAK were filed in the last 90 days, totaling $13.09M.
Where can I see TAK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TAK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lauren Rusckowski Duprey view on EDGAR
- - Andrew Stewart Plump view on EDGAR
- - Andrew Stewart Plump view on EDGAR
- - Nicola Deidre Petal Greenway view on EDGAR
- - Awny Samaan Botros Farajallah view on EDGAR
- - Ramy Riad Ahmed Ibrahim view on EDGAR
- - Rhonda Janice Pacheco view on EDGAR
- - Lauren Rusckowski Duprey view on EDGAR
- - Andrew Stewart Plump view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TAK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TAK with a 7-day demo
- TAK on your watchlist
- Every TAK Form 4 filing on record
- Up to 3 months of TAK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
